(Q50097629)

24 February 2018

title

Dissecting Interleukin-6 Classic- and Trans-Signaling in Inflammation and Cancer. (English)

1 reference

24 February 2018

author

Stefan Rose-John

series ordinal

2

1 reference

24 February 2018

author name string

Christoph Garbers

series ordinal

1

1 reference

24 February 2018

language of work or name

English

0 references

publication date

1 January 2018

1 reference

24 February 2018

Methods in Molecular Biology

published in

1 reference

24 February 2018

volume

1725

1 reference

24 February 2018

page(s)

127-140

1 reference

24 February 2018

The pro- and anti-inflammatory properties of the cytokine interleukin-6.

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

The role of IL-6 in host defence against infections: immunobiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Haemopoietic receptors and helical cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Plasticity and cross-talk of interleukin 6-type cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Molecular cloning and expression of an IL-6 signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Interleukin-6: Biology, signaling and strategies of blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

The soluble interleukin-6 receptor is generated by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Soluble receptors for cytokines and growth factors: generation and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Conservation of IL-6 trans-signaling mechanisms controlling L-selectin adhesion by fever-range thermal stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Maintenance of pluripotency in human embryonic stem cells is STAT3 independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Interleukin-6 and neural stem cells: more than gliogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Hyper-IL-6 gene therapy reverses fulminant hepatic failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Transgenic blockade of interleukin 6 transsignaling abrogates inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL-6 Trans-Signaling Drives Murine Crescentic GN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Peripheral and central blockade of interleukin-6 trans-signaling differentially affects sleep architecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

GP130 activation induces myeloma and collaborates with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-7568-6_11

10.1007/978-1-4939-7568-6_11

21 January 2018

Identifiers

DOI

1 reference

24 February 2018

PubMed ID

29322414

1 reference

24 February 2018